265 related articles for article (PubMed ID: 23820419)
1. Targeting adenoviral vectors for enhanced gene therapy of uterine leiomyomas.
Nair S; Curiel DT; Rajaratnam V; Thota C; Al-Hendy A
Hum Reprod; 2013 Sep; 28(9):2398-406. PubMed ID: 23820419
[TBL] [Abstract][Full Text] [Related]
2. Targeted Adenoviral Vector Demonstrates Enhanced Efficacy for In Vivo Gene Therapy of Uterine Leiomyoma.
Abdelaziz M; Sherif L; ElKhiary M; Nair S; Shalaby S; Mohamed S; Eziba N; El-Lakany M; Curiel D; Ismail N; Diamond MP; Al-Hendy A
Reprod Sci; 2016 Apr; 23(4):464-74. PubMed ID: 26884457
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy of uterine leiomyoma: adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir treatment inhibits growth of human and rat leiomyoma cells in vitro and in a nude mouse model.
Salama SA; Kamel M; Christman G; Wang HQ; Fouad HM; Al-Hendy A
Gynecol Obstet Invest; 2007; 63(2):61-70. PubMed ID: 16954695
[TBL] [Abstract][Full Text] [Related]
4. Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model.
Hassan M; Zhang D; Salama S; Hamada F; Arafa H; Fouad H; Walker C; Al-Hendy A
Gynecol Obstet Invest; 2009; 68(1):19-32. PubMed ID: 19325244
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Hum Reprod; 2013 Sep; 28(9):2407-16. PubMed ID: 23814095
[TBL] [Abstract][Full Text] [Related]
6. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.
Hassan MH; Salama SA; Zhang D; Arafa HM; Hamada FM; Fouad H; Walker CC; Al-Hendy A
Fertil Steril; 2010 Jan; 93(1):239-50. PubMed ID: 19144333
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
9. Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer.
Matthews K; Noker PE; Tian B; Grimes SD; Fulton R; Schweikart K; Harris R; Aurigemma R; Wang M; Barnes MN; Siegal GP; Hemminki A; Zinn K; Curiel DT; Alvarez RD
Clin Cancer Res; 2009 Jun; 15(12):4131-7. PubMed ID: 19509153
[TBL] [Abstract][Full Text] [Related]
10. Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells.
Shalaby SM; Khater MK; Perucho AM; Mohamed SA; Helwa I; Laknaur A; Lebedyeva I; Liu Y; Diamond MP; Al-Hendy AA
Fertil Steril; 2016 Jun; 105(6):1638-1648.e8. PubMed ID: 27020169
[TBL] [Abstract][Full Text] [Related]
11. Killing effect of coexpressing cytosine deaminase and thymidine kinase on rat vascular smooth muscle cells.
Cao HQ; Meng XM; Liu DQ; Zhao XW; Ding JF
Chin Med J (Engl); 2004 Oct; 117(10):1464-70. PubMed ID: 15498366
[TBL] [Abstract][Full Text] [Related]
12. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
13. ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells.
Zu B; Shi Y; Xu M; You G; Huang Z; Gao M; Feng W
J Exp Clin Cancer Res; 2015 May; 34(1):56. PubMed ID: 26017281
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
Mizuguchi H; Hayakawa T
Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439
[TBL] [Abstract][Full Text] [Related]
15. Imaging of viral thymidine kinase gene expression by replicating oncolytic adenovirus and prediction of therapeutic efficacy.
Kim EJ; Yoo JY; Choi YH; Ahn KJ; Lee JD; Yun CO; Yun M
Yonsei Med J; 2008 Oct; 49(5):811-8. PubMed ID: 18972602
[TBL] [Abstract][Full Text] [Related]
16. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.
Wildner O; Hoffmann D; Jogler C; Uberla K
Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232
[TBL] [Abstract][Full Text] [Related]
17. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
Sutton MA; Berkman SA; Chen SH; Block A; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Woo SL; Lerner SP
Urology; 1997 Feb; 49(2):173-80. PubMed ID: 9037277
[TBL] [Abstract][Full Text] [Related]
19. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice.
Al-Hendy A; Lee EJ; Wang HQ; Copland JA
Am J Obstet Gynecol; 2004 Nov; 191(5):1621-31. PubMed ID: 15547533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]